CLINICAL_TRIALS
trial_result
· 2016-12-07
Clinical Trial Update: Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125) [Phase 3]
Summary
Phase 3 trial update evaluating inhaled ciclesonide in adult asthma patients (BY9010/M1-125).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED